.png)
_(1).png){kind=logo}
Characteristics of Patients with Type 2 Diabetes Mellitus in Al-Ihsan Regional General Hospital
Abstract
The prevalence of type 2 diabetes mellitus (T2DM) in Indonesia is high, contributing to the fourth mortality rate for non-communicable diseases in Indonesia. The population of T2DM patients spread across all provinces, including West Java, which is the most populous province in Indonesia. One of the referral hospitals in West Java is Al-Ihsan Regional General Hospital in Bandung regency. The purpose of this study was to describe the characteristics of T2DM patients who came to Al-Ihsan Regional General Hospital according to age, gender, and comorbidities parameters. It was a descriptive cross-sectional study using secondary data from medical records of T2DM patients between January 2017 and November 2020. The results were the highest prevalence and incidence of T2DM were in 2017 with as many as 5,051 and 653 respectively; the highest gender each year was female, range between 584–3,333, with the highest male: female ratio of 1:2 in 2017; the age group with the highest prevalence was 55–65 years which was 3,468 (39.53%); and top five comorbidities were hypertension (35.68%), cataracts (6.01%), osteoarthritis (3.58%), pulmonary tuberculosis (2.92%) and dyspepsia (2.91%). This study concluded that the prevalence and incidence of T2DM in Al-Ihsan Regional General Hospital were high, with the predominant female patients, elderly, and comorbid hypertension.
KARAKTERISTIK PASIEN DIABETES MELITUS TIPE 2 DI RSUD AL-IHSAN
Angka kejadian diabetes melitus tipe 2 (DMT2) di Indonesia cukup tinggi, menyumbangkan angka kematian keempat penyakit tidak menular di Indonesia. Penderita DMT2 tersebar di seluruh provinsi, termasuk Jawa Barat yang merupakan provinsi terpadat di Indonesia. Salah satu rumah sakit rujukan di Jawa Barat adalah RSUD Al-Ihsan di Kabupaten Bandung. Tujuan penelitian ini adalah menggambarkan karakteristik pasien DMT2 yang datang ke RSUD Al-Ihsan dilihat dari usia, jenis kelamin, dan komorbid. Penelitian ini merupakan penelitian deskriptif cross-sectional menggunakan data sekunder berupa rekam medis pasien DMT2 periode Januari 2017 hingga November 2020. Didapatkan bahwa prevalensi dan insidensi DMT2 tertinggi pada tahun 2017 sebesar 5.051 dan 653 masing-masing; jenis kelamin terbanyak pada setiap tahun adalah wanita sebesar 584–3.333 dengan rasio pria:wanita tertinggi 1:2 pada tahun 2017; kelompok usia dengan prevalensi tertinggi adalah 55–65 tahun sebesar 3.468 (39,53%); dan lima komorbid tertinggi adalah hipertensi (35,68%), katarak (6,01%), osteoartritis (3,58%), tuberkulosis paru (2,92%), dan dispepsia (2,91%). Simpulan penelitian ini adalah prevalensi dan insidensi DMT2 di RSUD Al-Ihsan tinggi dengan pasien terbanyak wanita, lanjut usia, dan komorbid hipertensi.
Keywords
Full Text:
PDFReferences
International Diabetes Federation. IDF diabetes atlas. 9th Edition. Brussels, Belgium: International Diabetes Federation; 2019.
Kementerian Kesehatan Republik Indonesia. Laporan nasional Riskesdas 2018. Jakarta: Lembaga Penerbit Badan Penelitian dan Pengembangan Kesehatan; 2019.
Kementerian Kesehatan Republik Indonesia. Laporan Provinsi Jawa Barat Riskesdas 2018. Jakarta: Lembaga Penerbit Badan Penelitian dan Pengembangan Kesehatan; 2019.
United Nations Statistical Commission. The Indonesian population census 2020 highlights [Internet]. New York: United Nations Statistical Commission; 2021 [cited 2021 June 13]. Available from: https://unstats.un.org/unsd/demographic-social/meetings/2021/egm-covid19-census-20210209/docs/s03-04-IDN.pdf.
Persatuan Diabetes Indonesia dan Perkumpulan Endokrinologi Indonesia. Pedoman pengelolaan dan pencegahan prediabetes di Indonesia 2019. Surabaya: Airlangga University Press; 2020.
Yuan H, Li X, Wan G, Sun L, Zhu X, Che F, et al. Type 2 diabetes epidemic in East Asia: a 35-year systematic trend analysis. Oncotarget. 2017;9(6):6718–27.
Ramachandran A, Snehalatha C, Shetty AS, Nanditha A. Trends in prevalence of diabetes in Asian countries. World J Diabetes. 2012;3(6):110–7.
Gupta P, Jadon SS. Effect of changing lifestyle on urban pattern. AIP Conf Proc. 2019;2158(1):020024.
Oliveira GM, Vidal DG, Ferraz MP. Urban lifestyles and consumption patterns. In: Filho WL, Azul AM, Brandli L, Özuyar PG, Wall T, editors. Sustainable cities and communities (Encyclopedia of the UN Sustainable Development Goals. Cham: Springer Nature Switzerland AG; 2020. p. 851–60.
Suyanto B, Sugihartati R, Hidayat M, Subiakto H. Global vs. local: lifestyle and consumption behaviour among the urban middle class in East Java, Indonesia. South East Asia Res. 2020;27(4):398–417.
World Health Organization. COVID-19 significantly impacts health services for noncommunicable diseases [Internet]. Geneva: World Health Organization; 2020 June 1 [cited 2021 June 13]. Available from: https://www.who.int/news/item/01-06-2020-covid-19-significantly-impacts-health-services-for-noncommunicable-diseases.
Ghosal S, Arora B, Dutta K, Ghosh A, Sinha B, Misra A. Increase in the risk of type 2 diabetes during lockdown for the COVID19 pandemic in India: a cohort analysis. Diabetes Metab Syndr Clin Res Rev. 2020;14(5):949–52.
Fukushima N, Machida M, Kikuchi H, Amagasa S, Hayashi T, Odagiri Y, et al. Associations of working from home with occupational physical activity and sedentary behavior under the COVID-19 pandemic. J Occup Health. 2021;63(1):e12212.
World Health Organization. The impact of the COVID-19 pandemic on noncommunicable disease resources and services: results of a rapid assessment. Geneva: World Health Organization; 2020.
Patil VS, Mankar SD. Impact of COVID-19 pandemic on management of other disease. IJPSR. 2020;11(6):147–51.
Clague C. The impact of COVID-19 on non-communicable diseases in Asia. London: Economist Intelligence Unit; 2021 February 22 [cited 2021 June 13]. Available from: https://eiuperspectives.economist.com/healthcare/impact-covid-19-non-communicable-diseases-asia.
Badan Pusat Statistik Kabupaten Bandung. Indeks kesejahteraan rakyat Kabupaten Bandung 2020 [Internet]. Bandung: BPS Kabupaten Bandung; 2020 December 11 [cited 2021 June 13]. Available from: https://bandungkab.bps.go.id/publication/2020/12/11/ab19209451b09890a214b099/indeks-kesejahteraan-rakyat-kabupaten-bandung-2020.html.
Aguilar-Salinas CA, Velazquez Monroy O, Gómez-Pérez FJ, Gonzalez Chávez A, Esqueda AL, Molina Cuevas V, et al. Characteristics of patients with type 2 diabetes in México: results from a large population-based nationwide survey. Diabetes Care. 2003;26(7):2021–6.
Vijayakumar G, Manghat S, Vijayakumar S, Simon L, Scaria LM, Vijayakumar A, et al. Incidence of type 2 diabetes mellitus and prediabetes in Kerala, India: results from a 10-year prospective cohort. BMC Public Health. 2019;19(1):140.
Al Mansour MA. The prevalence and risk factors of type 2 diabetes mellitus (DMT2) in a semi-urban Saudi population. Int J Environ Res Public Health. 2019;17(1):7.
Nordström A, Hadrévi J, Olsson T, Franks PW, Nordström P. Higher prevalence of type 2 diabetes in men than in women is associated with differences in visceral fat mass. J Clin Endocrinol Metab. 2016;101(10):3740–6.
Arnetz L, Ekberg NR, Alvarsson M. Sex differences in type 2 diabetes: focus on disease course and outcome. Diabetes Metab Syndr Obes. 2014;7:409–20.
Harreiter J, Kautzky-Willer A. Sex and gender differences in prevention of type 2 diabetes gender medicine unit. Front Endocrinol (Lausanne). 2018;9(5):220.
Kasznicki J, Głowacka A, Drzewoski J. Type 2 diabetic patients compliance with drug therapy and glycaemic control. Diabetol Dosw Klin. 2007;7(4):199–203.
Zahari AZ, Yunivita KD, Martha JW. Knowledge, attitude and practice of diabetes mellitus type 2 patients towards compliance to treatment in pusat kesehatan masyarakat. Althea Med J. 2016;3(3):416–20.
Hillier TA, Pedula KL. Characteristics of an adult population with newly diagnosed type 2 diabetes: the relation of obesity and age of onset. Diabetes Care. 2001;24(9):1522–7.
Wilmot E, Idris I. Early onset type 2 diabetes: risk factors, clinical impact and management. Ther Adv Chronic Dis. 2014;5(6):234–44.
Grundy SM. Pre-diabetes, metabolic syndrome, and cardiovascular risk. J Am Coll Cardiol. 2012;59(7):635–43.
Huang CL, Iqbal U, Nguyen PA, Chen ZF, Clinciu DL, Hsu YHE, et al. Using hemoglobin A1C as a predicting model for time interval from pre-diabetes progressing to diabetes. PLoS One. 2014;9(8):e104263.
Aldossari KK, Aldiab A, Al-Zahrani JM, Al-Ghamdi SH, Abdelrazik M, Batais MA, et al. Prevalence of prediabetes, diabetes, and its associated risk factors among males in Saudi Arabia: a population-based survey. J Diabetes Res. 2018;2018:2194604.
Wang J, Ma JJ, Liu J, Zeng DD, Song C, Cao Z. Prevalence and risk factors of comorbidities among hypertensive patients in China. Int J Med Sci. 2017;14(3):201–12.
Feng L, Naheed A, de Silva HA, Jehan I, Raqib R, Islam MT, et al. Regional variation in comorbid prediabetes and diabetes and associated factors among hypertensive individuals in rural Bangladesh, Pakistan, and Sri Lanka. J Obes. 2019;2019:4914158.
Jelinek HF, Osman WM, Khandoker AH, Khalaf K, Lee S, Almahmeed W, et al. Clinical profiles, comorbidities and complications of type 2 diabetes mellitus in patients from United Arab Emirates. BMJ Open Diabetes Res Care. 2017;5(1):e000427.
Ighodaro OM. Molecular pathways associated with oxidative stress in diabetes mellitus. Biomed Pharmacother. 2018;108:656–62.
Brownlee M. The pathobiology of diabetic complications a unifying mechanism. Diabetes. 2005;54(6):1615–25.
Ohishi M. Hypertension with diabetes mellitus: physiology and pathology: review. Hypertens Res. 2018;41(6):389–93.
Raman R, Pal SS, Adams JSK, Rani PK, Vaitheeswaran K, Sharma T. Prevalence and risk factors for cataract in diabetes: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study, report no. 17. Invest Ophthalmol Vis Sci. 2010;51(12):6253–61.
Srinivasan S, Raman R, Swaminathan G, Ganesan S, Kulothungan V, Sharma T. Incidence, progression, and risk factors for cataract in type 2 diabetes. Invest Ophthalmol Vis Sci. 2017;58(13):5921–9.
Pollreisz A, Schmidt-Erfurth U. Diabetic cataract—pathogenesis, epidemiology and treatment. J Ophthalmol. 2010;2010:608751.
Kiziltoprak H, Tekin K, Inanc M, Goker YS. Cataract in diabetes mellitus. World J Diabetes. 2019;10(3):140–53.
Veronese N, Cooper C, Reginster JY, Hochberg M, Branco J, Bruyère O, et al. Type 2 diabetes mellitus and osteoarthritis. Semin Arthritis Rheum. 2019;49(1):9–19.
Piva SR, Susko AM, Khoja SS, Josbeno DA, Fitzgerald GK, Frederico G, et al. Links between osteoarthritis and diabetes: implications for management from a physical activity perspective. Clin Geriatr Med. 2015;31(1):67–87.
Tchetina EV, Markova GA, Sharapova EP. Insulin resistance in osteoarthritis: similar mechanisms to type 2 diabetes mellitus. J Nutr Metab. 2020;2020:4143802.
Rosa SC, Rufino AT, Judas F, Tenreiro C, Lopes MC, Mendes AF. Expression and function of the insulin receptor in normal and osteoarthritic human chondrocytes: modulation of anabolic gene expression, glucose transport and GLUT-1 content by insulin. Osteoarthritis Cartilage. 2011;19(6):719–27.
Tenaye L, Mengiste B, Baraki N, Mulu E. Diabetes mellitus among adult tuberculosis patients attending tuberculosis clinics in Eastern Ethiopia. Biomed Res Int. 2019;2019:7640836.
Sasmita HY, Prasetyowati I, Wahjudi P. Prevalence and risk factors of diabetes mellitus in tuberculosis patient at Patrang district Indonesia. IJTID. 2019;7(4):79–85.
Restrepo BI. Diabetes and tuberculosis. Microbiol Spectr. 2016;4(6):TNMI7-0023-2016.
Teskey G, Cao R, Cerni S, Chang L, Fahmy K, Geiger J, et al. The pathogenesis of tuberculosis-diabetes comorbidity. MRA. 2017;5(12):1613.
Krishnasamy S, Abell TL. Diabetic gastroparesis: principles and current trends in management. Diabetes Ther. 2018;9(Suppl 1):1–42.
Camilleri M, Bharucha AE, Farrugia G. Epidemiology, mechanisms and management of diabetic gastroparesis. Clin Gastroenterol Hepatol. 2011;9(1):5–12.
Kumar M, Chapman A, Javed S, Alam U, Malik RA, Azmi S. The investigation and treatment of diabetic gastroparesis. Clin Ther. 2018;40(6):850–61.
Parkman HP. The pathophysiology of diabetic gastroparesis. Gastroenterol Hepatol (NY). 2010;6(Suppl 9):3–5.
DOI: https://doi.org/10.29313/gmhc.v9i2.8123
pISSN 2301-9123 | eISSN 2460-5441
Visitor since 19 October 2016:
_(1).jpg){kind=logo}
Global Medical and Health Communication is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.